Search

Your search keyword '"Delage, R"' showing total 156 results
Start Over Author "Delage, R"
156 results on '"Delage, R"'

1. Human spaceflight from Guiana Space Center

Author

Bonnal, Ch, Bahu, J.-M., Berthe, Ph, Bertrand, J., Bonhomme, Ch, Caporicci, M., Clervoy, J.-F., Costedoat, N., Coletti, E., Collange, G., Debas, G., Delage, R., Droz, J., Louaas, E., Marx, P., Muller, B., Perezzan, S., Quinquis, I., Sandrone, S., Schmitt, D., and Taponier, V.

Published
2021
Full Text
View/download PDF

2. An MDS-specific frailty index based on cumulative deficits adds independent prognostic information to clinical prognostic scoring

Author

Starkman, R., Alibhai, S., Wells, R. A., Geddes, M., Zhu, N., Keating, M. M., Leber, B., Chodirker, L., Sabloff, M., Christou, G., Leitch, H. A., St-Hilaire, E., Finn, N., Shamy, A., Yee, K., Storring, J., Nevill, T., Delage, R., Elemary, M., Banerji, V., Lenis, M., Kirubananthaan, A., Mamedov, A., Zhang, L., Rockwood, K., and Buckstein, R.

Published
2020
Full Text
View/download PDF

3. Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial

Author

Cerana, S, Dictar, MO, Bonvehi, P, Tregnaghi, JP, Fein, L, Ashley, D, Singh, M, Hayes, T, Playford, G, Morrissey, O, Thaler, J, Kuehr, T, Greil, R, Pecherstorfer, M, Duck, L, Van Eygen, K, Aoun, M, De Prijck, B, Franke, FA, Barrios, CHE, Mendes, AVA, Serrano, SV, Garcia, RF, Moore, F, Camargo, JFC, Pires, LA, Alves, RS, Radinov, A, Oreshkov, K, Minchev, V, Hubenova, AI, Koynova, T, Ivanov, I, Rabotilova, B, Petrov, PA, Chilingirov, P, Karanikolov, S, Raynov, J, Grimard, D, McNeil, S, Kumar, D, Larratt, LM, Weiss, K, Delage, R, Diaz-Mitoma, FJ, Cano, PO, Couture, F, Carvajal, P, Yepes, A, Torres Ulloa, R, Fardella, P, Caglevic, C, Rojas, C, Orellana, E, Gonzalez, P, Acevedo, A, Galvez, KM, Gonzalez, ME, Franco, S, Restrepo, JG, Rojas, CA, Bonilla, C, Florez, LE, Ospina, AV, Manneh, R, Zorica, R, Vrdoljak, DV, Samarzija, M, Petruzelka, L, Vydra, J, Mayer, J, Cibula, D, Prausova, J, Paulson, G, Ontaneda, M, Palk, K, Vahlberg, A, Rooneem, R, Galtier, F, Postil, D, Lucht, F, Laine, F, Launay, O, Laurichesse, H, Duval, X, Cornely, OA, Camerer, B, Panse, J, Zaiss, M, Derigs, H-G, Menzel, H, Verbeek, M, Georgoulias, V, Mavroudis, D, Anagnostopoulos, A, Terpos, E, Cortes, D, Umanzor, J, Bejarano, S, Galeano, RW, Wong, RSM, Hui, P, Pedrazzoli, P, Ruggeri, L, Aversa, F, Bosi, A, Gentile, G, Rambaldi, A, Contu, A, Marei, L, Abbadi, A, Hayajneh, W, Kattan, J, Farhat, F, Chahine, G, Rutkauskiene, J, Marfil Rivera, LJ, Lopez Chuken, YA, Franco Villarreal, H, Lopez Hernandez, J, Blacklock, H, Lopez, RI, Alvarez, R, Gomez, AM, Quintana, TS, Moreno Larrea, MDC, Zorrilla, SJ, Alarcon, E, Samanez, FCA, Caguioa, PB, Tiangco, BJ, Mora, EM, Betancourt-Garcia, RD, Hallman-Navarro, D, Feliciano-Lopez, LJ, Velez-Cortes, HA, Cabanillas, F, Ganea, DE, Ciuleanu, TE, Ghizdavescu, DG, Miron, L, Cebotaru, CL, Cainap, CI, Anghel, R, Dvorkin, MV, Gladkov, OA, Fadeeva, NV, Kuzmin, AA, Lipatov, ON, Zbarskaya, II, Akhmetzyanov, FS, Litvinov, IV, Afanasyev, BV, Cherenkova, M, Lioznov, D, Lisukov, IA, Smirnova, YA, Kolomietz, S, Halawani, H, Goh, YT, Drgona, L, Chudej, J, Matejkova, M, Reckova, M, Rapoport, BL, Szpak, WM, Malan, DR, Jonas, N, Jung, CW, Lee, DG, Yoon, SS, Lopez Jimenez, J, Duran Martinez, I, Rodriguez Moreno, JF, Solano Vercet, C, de la Camara, R, Batlle Massana, M, Yeh, S-P, Chen, C-Y, Chou, H-H, Tsai, C-M, Chiu, C-H, Siritanaratkul, N, Norasetthada, L, Sriuranpong, V, Seetalarom, K, Akan, H, Dane, F, Ozcan, MA, Ozsan, GH, Kalayoglu Besisik, SF, Cagatay, A, Yalcin, S, Peniket, A, Mullan, SR, Dakhil, KM, Sivarajan, K, Suh, JJ-G, Sehgal, A, Marquez, F, Gomez, EG, Mullane, MR, Skinner, WL, Behrens, RJ, Trevarthe, DR, Mazurczak, MA, Lambiase, EA, Vidal, CA, Anac, SY, Rodrigues, GA, Baltz, B, Boccia, R, Wertheim, MS, Holladay, CS, Zenk, D, Fusselman, W, Wade III, JL, Jaslowsk, AJ, Keegan, J, Robinson, MO, Go, RS, Farnen, J, Amin, B, Jurgens, D, Risi, GF, Jr, Beatty, PG, Naqvi, T, Parshad, S, Hansen, VL, Ahmed, M, Steen, PD, Badarinath, S, Dekker, A, Scouros, MA, Young, DE, Graydon Harker, W, Kendall, SD, Citron, ML, Chedid, S, Posada, JG, Jr, Gupta, MK, Rafiyath, S, Buechler-Price, J, Sreenivasappa, S, Chay, CH, Burke, JM, Young, SE, Mahmood, A, Kugler, JW, Gerstner, G, Fuloria, J, Belman, ND, Geller, R, Nieva, J, Whittenberger, BP, Wong, BMY, Cescon, TP, Abesada-Terk, G, Jr, Guarino, MJ, Zweibach, A, Ibrahim, EN, Takahashi, G, Garrison, MA, Mowat, RB, Choi, BS, Oliff, IA, Singh, J, Guter, KA, Ayrons, K, Rowland, KM, Noga, SJ, Rao, SB, Columbie, A, Nualart, MT, Cecchi, GR, Campos, LT, Mohebtash, M, Flores, MR, Rothstein-Rubin, R, O'Connor, BM, Soori, G, Knapp, M, Miranda, FG, Goodgame, BW, Kassem, M, Belani, R, Sharma, S, Ortiz, T, Sonneborn, HL, Markowitz, AB, Wilbur, D, Meiri, E, Koo, VS, Jhangiani, HS, Wong, L, Sanani, S, Lawrence, SJ, Jones, CM, Murray, C, Papageorgiou, C, Gurtler, JS, Ascensao, JL, Venigalla, ML, D'Andrea, M, De Las Casas, C, Haile, DJ, Qazi, FU, Santander, JL, Thomas, MR, Rao, VP, Craig, M, Garg, RJ, Robles, R, Lyons, RM, Stegemoller, RK, Goel, S, Garg, S, Lowry, P, Lynch, C, Lash, B, Repka, T, Baker, J, Goueli, BS, Campbell, TC, Van Echo, DA, Lee, YJ, Reyes, EA, Senecal, FM, Donnelly, G, Byeff, P, Weiss, R, Reid, T, Roeland, E, Goel, A, Prow, DM, Brandt, DS, Kaplan, HG, Payne, JE, Boeckh, MG, Rosen, PJ, Mena, RR, Khan, R, Betts, RF, Sharp, SA, Morrison, VA, Fitz-Patrick, D, Congdon, J, Erickson, N, Abbasi, R, Henderson, S, Mehdi, A, Wos, EJ, Rehmus, E, Beltzer, L, Tamayo, RA, Mahmood, T, Reboli, AC, Moore, A, Brown, JM, Cruz, J, Quick, DP, Potz, JL, Kotz, KW, Hutchins, M, Chowhan, NM, Devabhaktuni, YD, Braly, P, Berenguer, RA, Shambaugh, SC, O'Rourke, TJ, Conkright, WA, Winkler, CF, Addo, FEK, Duic, JP, High, KP, Kutner, ME, Collins, R, Carrizosa, DR, Perry, DJ, Kailath, E, Rosen, N, Sotolongo, R, Shoham, S, Chen, T, Mullane, Kathleen M, Morrison, Vicki A, Camacho, Luis H, Arvin, Ann, McNeil, Shelly A, Durrand, Jessie, Campbell, Bernadette, Su, Shu-Chih, Chan, Ivan S F, Parrino, Janie, Kaplan, Susan S, Popmihajlov, Zoran, and Annunziato, Paula W

Published
2019
Full Text
View/download PDF

4. Topic: AS09-Quality of life-Disease experiences: LONGITUDINAL TRAJECTORY OF QUALITY OF LIFE IN MDS AND IMPACT OF PATIENT-RELATED FACTORS

Author

Buckstein, R., primary, Chodirker, L., additional, Mozessohn, L., additional, Geddes, M., additional, Zhu, N., additional, Trottier, A., additional, Khalaf, D., additional, Leber, B., additional, St-Hilaire, E., additional, Finn, N., additional, Sabloff, M., additional, Christou, G., additional, Leitch, H., additional, Shamy, A., additional, Yee, K., additional, Storring, J., additional, Nevill, T., additional, Elemary, M., additional, Delage, R., additional, Houston, B., additional, Parmentier, A., additional, Siddiqui, M., additional, Mamedov, A., additional, Zhang, L., additional, and Abel, G., additional

Published
2023
Full Text
View/download PDF

5. Topic: AS02-Epidemiology: EVALUATION OF INFECTIOUS COMPLICATIONS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES: A PROSPECTIVE COHORT STUDY FROM THE CANADIAN MDS REGISTRY

Author

Mathur, S., primary, Christou, G., additional, Delage, R., additional, Elemary, M., additional, Finn, N., additional, Geddes, M., additional, Houston, D., additional, Keating, M.-M., additional, Khalaf, D., additional, Leber, B., additional, Leitch, H., additional, Lother, S., additional, Mozessohn, L., additional, Nevill, T., additional, Parmentier, A., additional, Paulson, K., additional, Rimmer, E., additional, Sabloff, M., additional, Shamy, A., additional, St-Hilaire, E., additional, Storring, J., additional, Yee, K., additional, Zhang, L., additional, Zhu, N., additional, Hay, A., additional, Zarychanski, R., additional, Buckstein, R., additional, and Houston, B., additional

Published
2023
Full Text
View/download PDF

7. P143 - Topic: AS09-Quality of life-Disease experiences: LONGITUDINAL TRAJECTORY OF QUALITY OF LIFE IN MDS AND IMPACT OF PATIENT-RELATED FACTORS

Author

Buckstein, R., Chodirker, L., Mozessohn, L., Geddes, M., Zhu, N., Trottier, A., Khalaf, D., Leber, B., St-Hilaire, E., Finn, N., Sabloff, M., Christou, G., Leitch, H., Shamy, A., Yee, K., Storring, J., Nevill, T., Elemary, M., Delage, R., Houston, B., Parmentier, A., Siddiqui, M., Mamedov, A., Zhang, L., and Abel, G.

Published
2023
Full Text
View/download PDF

8. P025 - Topic: AS02-Epidemiology: EVALUATION OF INFECTIOUS COMPLICATIONS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES: A PROSPECTIVE COHORT STUDY FROM THE CANADIAN MDS REGISTRY

Author

Mathur, S., Christou, G., Delage, R., Elemary, M., Finn, N., Geddes, M., Houston, D., Keating, M.-M., Khalaf, D., Leber, B., Leitch, H., Lother, S., Mozessohn, L., Nevill, T., Parmentier, A., Paulson, K., Rimmer, E., Sabloff, M., Shamy, A., St-Hilaire, E., Storring, J., Yee, K., Zhang, L., Zhu, N., Hay, A., Zarychanski, R., Buckstein, R., and Houston, B.

Published
2023
Full Text
View/download PDF

9. S159: QUÉBEC CML RESEARCH GROUP ANALYSIS OF TREATMENT PATTERNS IN CHRONIC MYELOGENOUS LEUKEMIA: SWITCHING IS DRIVEN BY INTOLERANCE AND SIMILAR ACROSS TYROSINE KINASE INHIBITORS AND LINES OF TREATMENT

Author

Busque, L., primary, Harnois, M., additional, Szuber, N., additional, Delage, R., additional, Mollica, L., additional, Olney, H., additional, Laneuville, P., additional, Sirhan, S., additional, Cournoyer, G., additional, Chamakhi, I., additional, Lalancette, M., additional, Talbot, D., additional, Éthier, V., additional, Desjardins, P., additional, and Assouline, S., additional

Published
2022
Full Text
View/download PDF

10. S158: FINAL RESULT OF TKI DISCONTINUATION TRIAL WITH DASATINIB FOR SECOND ATTEMPT OF TREATMENT FREE REMISSION AFTER FAILING FIRST ATTEMPT WITH IMATINIB: TREATMENT-FREE REMISSION ACCOMPLISHED BY DASATINIB

Author

Kim, D., primary, Atenafu, E., additional, Forrest, D., additional, Bence-Bruckler, I., additional, Savoie, L., additional, Keating, M.-M., additional, Busque, L., additional, Delage, R., additional, Xenocostas, A., additional, Liew, E., additional, Laneuville, P., additional, Paulson, K., additional, Stockley, T., additional, Lipton, J., additional, and Leber, B., additional

Published
2022
Full Text
View/download PDF

12. P09 - Topic: AS02-Epidemiology: THE IMPACT OF GAINING OR LOSING TRANSFUSION INDEPENDENCE ON QUALITY OF LIFE IN MYELODYSPLASTIC SYNDROMES

Author

Brailovski, E., Mozessohn, L., Abel, G., Geddes, M., Zhu, N., Keating, M.-M., Sabloff, M., Christou, G., Leber, B., Khalaf, D., Leitch, H., Hilaire, E. St., Finn, N., Shamy, A., Yee, K., Storring, J., Nevill, T., Delage, R., Elemary, M., Banerji, V., Houston, B., Chodirker, L., Parmentier, A., Siddiqui, M., Mamedov, A., Zhang, L., and Buckstein, R.

Published
2021
Full Text
View/download PDF

14. Topic: AS08-Treatment/AS08j-Supportive care - Iron overload

Author

Leitch, H., primary, Ezzat, H., additional, Merkeley, H., additional, Buckstein, R., additional, Zhu, N., additional, Nevill, T., additional, Olney, H., additional, Yee, K., additional, Leber, B., additional, Keating, M.-M., additional, Hilaire, E. St., additional, Kumar, R., additional, Delage, R., additional, Geddes, M., additional, Storring, J., additional, Shamy, A., additional, Elemary, M., additional, and Wells, R., additional

Published
2021
Full Text
View/download PDF

15. Topic: AS02-Epidemiology

Author

Brailovski, E., primary, Mozessohn, L., additional, Abel, G., additional, Geddes, M., additional, Zhu, N., additional, Keating, M.-M., additional, Sabloff, M., additional, Christou, G., additional, Leber, B., additional, Khalaf, D., additional, Leitch, H., additional, Hilaire, E. St., additional, Finn, N., additional, Shamy, A., additional, Yee, K., additional, Storring, J., additional, Nevill, T., additional, Delage, R., additional, Elemary, M., additional, Banerji, V., additional, Houston, B., additional, Chodirker, L., additional, Parmentier, A., additional, Siddiqui, M., additional, Mamedov, A., additional, Zhang, L., additional, and Buckstein, R., additional

Published
2021
Full Text
View/download PDF

19. An MDS-specific frailty index based on cumulative deficits adds independent prognostic information to clinical prognostic scoring

Author

Starkman, R., primary, Alibhai, S., additional, Wells, R. A., additional, Geddes, M., additional, Zhu, N., additional, Keating, M. M., additional, Leber, B., additional, Chodirker, L., additional, Sabloff, M., additional, Christou, G., additional, Leitch, H. A., additional, St-Hilaire, E., additional, Finn, N., additional, Shamy, A., additional, Yee, K., additional, Storring, J., additional, Nevill, T., additional, Delage, R., additional, Elemary, M., additional, Banerji, V., additional, Lenis, M., additional, Kirubananthaan, A., additional, Mamedov, A., additional, Zhang, L., additional, Rockwood, K., additional, and Buckstein, R., additional

Published
2019
Full Text
View/download PDF

24. Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial

Author

Mullane, Kathleen M, primary, Morrison, Vicki A, additional, Camacho, Luis H, additional, Arvin, Ann, additional, McNeil, Shelly A, additional, Durrand, Jessie, additional, Campbell, Bernadette, additional, Su, Shu-Chih, additional, Chan, Ivan S F, additional, Parrino, Janie, additional, Kaplan, Susan S, additional, Popmihajlov, Zoran, additional, Annunziato, Paula W, additional, Cerana, S, additional, Dictar, MO, additional, Bonvehi, P, additional, Tregnaghi, JP, additional, Fein, L, additional, Ashley, D, additional, Singh, M, additional, Hayes, T, additional, Playford, G, additional, Morrissey, O, additional, Thaler, J, additional, Kuehr, T, additional, Greil, R, additional, Pecherstorfer, M, additional, Duck, L, additional, Van Eygen, K, additional, Aoun, M, additional, De Prijck, B, additional, Franke, FA, additional, Barrios, CHE, additional, Mendes, AVA, additional, Serrano, SV, additional, Garcia, RF, additional, Moore, F, additional, Camargo, JFC, additional, Pires, LA, additional, Alves, RS, additional, Radinov, A, additional, Oreshkov, K, additional, Minchev, V, additional, Hubenova, AI, additional, Koynova, T, additional, Ivanov, I, additional, Rabotilova, B, additional, Petrov, PA, additional, Chilingirov, P, additional, Karanikolov, S, additional, Raynov, J, additional, Grimard, D, additional, McNeil, S, additional, Kumar, D, additional, Larratt, LM, additional, Weiss, K, additional, Delage, R, additional, Diaz-Mitoma, FJ, additional, Cano, PO, additional, Couture, F, additional, Carvajal, P, additional, Yepes, A, additional, Torres Ulloa, R, additional, Fardella, P, additional, Caglevic, C, additional, Rojas, C, additional, Orellana, E, additional, Gonzalez, P, additional, Acevedo, A, additional, Galvez, KM, additional, Gonzalez, ME, additional, Franco, S, additional, Restrepo, JG, additional, Rojas, CA, additional, Bonilla, C, additional, Florez, LE, additional, Ospina, AV, additional, Manneh, R, additional, Zorica, R, additional, Vrdoljak, DV, additional, Samarzija, M, additional, Petruzelka, L, additional, Vydra, J, additional, Mayer, J, additional, Cibula, D, additional, Prausova, J, additional, Paulson, G, additional, Ontaneda, M, additional, Palk, K, additional, Vahlberg, A, additional, Rooneem, R, additional, Galtier, F, additional, Postil, D, additional, Lucht, F, additional, Laine, F, additional, Launay, O, additional, Laurichesse, H, additional, Duval, X, additional, Cornely, OA, additional, Camerer, B, additional, Panse, J, additional, Zaiss, M, additional, Derigs, H-G, additional, Menzel, H, additional, Verbeek, M, additional, Georgoulias, V, additional, Mavroudis, D, additional, Anagnostopoulos, A, additional, Terpos, E, additional, Cortes, D, additional, Umanzor, J, additional, Bejarano, S, additional, Galeano, RW, additional, Wong, RSM, additional, Hui, P, additional, Pedrazzoli, P, additional, Ruggeri, L, additional, Aversa, F, additional, Bosi, A, additional, Gentile, G, additional, Rambaldi, A, additional, Contu, A, additional, Marei, L, additional, Abbadi, A, additional, Hayajneh, W, additional, Kattan, J, additional, Farhat, F, additional, Chahine, G, additional, Rutkauskiene, J, additional, Marfil Rivera, LJ, additional, Lopez Chuken, YA, additional, Franco Villarreal, H, additional, Lopez Hernandez, J, additional, Blacklock, H, additional, Lopez, RI, additional, Alvarez, R, additional, Gomez, AM, additional, Quintana, TS, additional, Moreno Larrea, MDC, additional, Zorrilla, SJ, additional, Alarcon, E, additional, Samanez, FCA, additional, Caguioa, PB, additional, Tiangco, BJ, additional, Mora, EM, additional, Betancourt-Garcia, RD, additional, Hallman-Navarro, D, additional, Feliciano-Lopez, LJ, additional, Velez-Cortes, HA, additional, Cabanillas, F, additional, Ganea, DE, additional, Ciuleanu, TE, additional, Ghizdavescu, DG, additional, Miron, L, additional, Cebotaru, CL, additional, Cainap, CI, additional, Anghel, R, additional, Dvorkin, MV, additional, Gladkov, OA, additional, Fadeeva, NV, additional, Kuzmin, AA, additional, Lipatov, ON, additional, Zbarskaya, II, additional, Akhmetzyanov, FS, additional, Litvinov, IV, additional, Afanasyev, BV, additional, Cherenkova, M, additional, Lioznov, D, additional, Lisukov, IA, additional, Smirnova, YA, additional, Kolomietz, S, additional, Halawani, H, additional, Goh, YT, additional, Drgona, L, additional, Chudej, J, additional, Matejkova, M, additional, Reckova, M, additional, Rapoport, BL, additional, Szpak, WM, additional, Malan, DR, additional, Jonas, N, additional, Jung, CW, additional, Lee, DG, additional, Yoon, SS, additional, Lopez Jimenez, J, additional, Duran Martinez, I, additional, Rodriguez Moreno, JF, additional, Solano Vercet, C, additional, de la Camara, R, additional, Batlle Massana, M, additional, Yeh, S-P, additional, Chen, C-Y, additional, Chou, H-H, additional, Tsai, C-M, additional, Chiu, C-H, additional, Siritanaratkul, N, additional, Norasetthada, L, additional, Sriuranpong, V, additional, Seetalarom, K, additional, Akan, H, additional, Dane, F, additional, Ozcan, MA, additional, Ozsan, GH, additional, Kalayoglu Besisik, SF, additional, Cagatay, A, additional, Yalcin, S, additional, Peniket, A, additional, Mullan, SR, additional, Dakhil, KM, additional, Sivarajan, K, additional, Suh, JJ-G, additional, Sehgal, A, additional, Marquez, F, additional, Gomez, EG, additional, Mullane, MR, additional, Skinner, WL, additional, Behrens, RJ, additional, Trevarthe, DR, additional, Mazurczak, MA, additional, Lambiase, EA, additional, Vidal, CA, additional, Anac, SY, additional, Rodrigues, GA, additional, Baltz, B, additional, Boccia, R, additional, Wertheim, MS, additional, Holladay, CS, additional, Zenk, D, additional, Fusselman, W, additional, Wade III, JL, additional, Jaslowsk, AJ, additional, Keegan, J, additional, Robinson, MO, additional, Go, RS, additional, Farnen, J, additional, Amin, B, additional, Jurgens, D, additional, Risi, GF, additional, Beatty, PG, additional, Naqvi, T, additional, Parshad, S, additional, Hansen, VL, additional, Ahmed, M, additional, Steen, PD, additional, Badarinath, S, additional, Dekker, A, additional, Scouros, MA, additional, Young, DE, additional, Graydon Harker, W, additional, Kendall, SD, additional, Citron, ML, additional, Chedid, S, additional, Posada, JG, additional, Gupta, MK, additional, Rafiyath, S, additional, Buechler-Price, J, additional, Sreenivasappa, S, additional, Chay, CH, additional, Burke, JM, additional, Young, SE, additional, Mahmood, A, additional, Kugler, JW, additional, Gerstner, G, additional, Fuloria, J, additional, Belman, ND, additional, Geller, R, additional, Nieva, J, additional, Whittenberger, BP, additional, Wong, BMY, additional, Cescon, TP, additional, Abesada-Terk, G, additional, Guarino, MJ, additional, Zweibach, A, additional, Ibrahim, EN, additional, Takahashi, G, additional, Garrison, MA, additional, Mowat, RB, additional, Choi, BS, additional, Oliff, IA, additional, Singh, J, additional, Guter, KA, additional, Ayrons, K, additional, Rowland, KM, additional, Noga, SJ, additional, Rao, SB, additional, Columbie, A, additional, Nualart, MT, additional, Cecchi, GR, additional, Campos, LT, additional, Mohebtash, M, additional, Flores, MR, additional, Rothstein-Rubin, R, additional, O'Connor, BM, additional, Soori, G, additional, Knapp, M, additional, Miranda, FG, additional, Goodgame, BW, additional, Kassem, M, additional, Belani, R, additional, Sharma, S, additional, Ortiz, T, additional, Sonneborn, HL, additional, Markowitz, AB, additional, Wilbur, D, additional, Meiri, E, additional, Koo, VS, additional, Jhangiani, HS, additional, Wong, L, additional, Sanani, S, additional, Lawrence, SJ, additional, Jones, CM, additional, Murray, C, additional, Papageorgiou, C, additional, Gurtler, JS, additional, Ascensao, JL, additional, Venigalla, ML, additional, D'Andrea, M, additional, De Las Casas, C, additional, Haile, DJ, additional, Qazi, FU, additional, Santander, JL, additional, Thomas, MR, additional, Rao, VP, additional, Craig, M, additional, Garg, RJ, additional, Robles, R, additional, Lyons, RM, additional, Stegemoller, RK, additional, Goel, S, additional, Garg, S, additional, Lowry, P, additional, Lynch, C, additional, Lash, B, additional, Repka, T, additional, Baker, J, additional, Goueli, BS, additional, Campbell, TC, additional, Van Echo, DA, additional, Lee, YJ, additional, Reyes, EA, additional, Senecal, FM, additional, Donnelly, G, additional, Byeff, P, additional, Weiss, R, additional, Reid, T, additional, Roeland, E, additional, Goel, A, additional, Prow, DM, additional, Brandt, DS, additional, Kaplan, HG, additional, Payne, JE, additional, Boeckh, MG, additional, Rosen, PJ, additional, Mena, RR, additional, Khan, R, additional, Betts, RF, additional, Sharp, SA, additional, Morrison, VA, additional, Fitz-Patrick, D, additional, Congdon, J, additional, Erickson, N, additional, Abbasi, R, additional, Henderson, S, additional, Mehdi, A, additional, Wos, EJ, additional, Rehmus, E, additional, Beltzer, L, additional, Tamayo, RA, additional, Mahmood, T, additional, Reboli, AC, additional, Moore, A, additional, Brown, JM, additional, Cruz, J, additional, Quick, DP, additional, Potz, JL, additional, Kotz, KW, additional, Hutchins, M, additional, Chowhan, NM, additional, Devabhaktuni, YD, additional, Braly, P, additional, Berenguer, RA, additional, Shambaugh, SC, additional, O'Rourke, TJ, additional, Conkright, WA, additional, Winkler, CF, additional, Addo, FEK, additional, Duic, JP, additional, High, KP, additional, Kutner, ME, additional, Collins, R, additional, Carrizosa, DR, additional, Perry, DJ, additional, Kailath, E, additional, Rosen, N, additional, Sotolongo, R, additional, Shoham, S, additional, and Chen, T, additional

Published
2019
Full Text
View/download PDF

26. PF410 DOUBLING TIME AFTER FIRST ATTEMPT OF IMATINIB DISCONTINUATION IS HELPFUL TO IDENTIFY THE BEST CANDIDATE FOR THE SECOND ATTEMPT FOR TREATMENT-FREE REMISSION WITH DASATINIB: CANADIAN TRAD TRIAL

Author

Kim, D., primary, Busque, L., additional, Forrest, D., additional, Savoie, L., additional, Bence-Bruckler, I., additional, Couban, S., additional, Delage, R., additional, Xenocostas, A., additional, Liew, E., additional, Paulson, K., additional, Laneuville, P., additional, Lipton, J., additional, Kamel-Reid, S., additional, and Leber, B., additional

Published
2019
Full Text
View/download PDF

27. Improved Survival from Transfusion Dependence in Lower-Risk MDS Receiving Iron Chelation, Adjusting for MDS and Patient Characteristics: An MDS-Can Analysis

Author

Leitch, H.A., primary, Wells, R.A., additional, Chodirker, L., additional, Zhu, N., additional, Nevill, T.J., additional, Yee, K.W.L., additional, Leber, B., additional, Keating, M.M., additional, Sabloff, M., additional, Hilaire, E. St., additional, Kumar, R., additional, Delage, R., additional, Geddes, M., additional, Storring, J.M., additional, Shamy, A., additional, Elemary, M., additional, Lenis, M., additional, Francis, J., additional, Zhang, L., additional, and Buckstein, R., additional

Published
2017
Full Text
View/download PDF

29. Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia

Author

Saglio G, Kim DW, Issaragrisil S, le Coutre P, Etienne G, Lobo C, Pasquini R, Clark RE, Hochhaus A, Hughes TP, Gallagher N, Hoenekopp A, Dong M, Haque A, Larson RA, Kantarjian HM, Moiraghi B, Perez M, Greil R, Valent P, Bosly A, Martiat P, Noens L, André M, Verhoef G, Conchon M, Souza C, Nonino A, Hungria V, Zanichelli MA, Colturato V, Forrest D, Lipton JH, Savoie ML, Delage R, Lalancette M, Quintero G, Gomez M, Klamova H, Faber E, Bjerrum OW, Fredriksen H, Vestergaard H, Marcher C, Kamel H, Elzawam H, Porkka K, Remes K, Reiffers J, Guilhot F, Facon T, Tulliez M, Guerci Bresler AP, Nicolini FE, Charbonnier A, Rea D, Johnson Ansah A, Legros L, Harousseau JL, Rigal Huguet F, Escoffre M, Gardembas M, Guyotat D, Cahn JY, Gattermann N, Ottmann O, Niederwieser D, Stegelmann F, Schafhausen P, Brümmendorf T, Duyster J, Blumenstengel K, Scheid C, Kneba M, Kwong YL, Masszi T, Petrini M, Alimena G, Di Raimondo F, Rosti G, Rotoli B, Pungolino E, Amadori S, Abruzzese E, Fioritoni G, Lauria F, Bosi A, Martelli M, Rambaldi A, Ferrara F, Nobile F, Gobbi M, Carella AM, Orlandi EM, Leoni P, Tiribelli M, Levis A, Imamura M, Takahashi N, Tsukamoto N, Chiba S, Nagai T, Okamoto S, Miura O, Kurokawa M, Ohnishi K, Toba K, Nakao S, Tomita A, Miyamura K, Hino M, Maeda Y, Kimura A, Kawaguchi T, Miyazaki Y, Nakaseko C, Jinnai I, Matsuda A, Matsumura I, Ishikawa J, Ohyashiki K, Okada M, Usuki K, Kobayashi Y, Ohishi K, Imai K, Miyawaki S, Kanda Y, Park SY, Kim HJ, Sohn SK, Lee KH, Jung CW, Ong TC, Gómez Almaguer D, Kassack J, Ossenkoppele GJ, Gedde Dahl T, Hjorth Hansen H, Jedrzejczak W, Dmoszynska A, Starzak Dwozdz J, Holowiecki J, Kyrcz Krzemieñ S, Kuliczkowski K, Zaritsky A, Turkina A, Pospelova T, Goh YT, Koh LP, Demitrovicova L, Mistrik M, Ruff P, Louw V, Dreosti LM, Novitzky N, Cohen G, Cervantes F, Cañizo C, de Paz R, del Castillo S, Perez Encinas M, Sanz Alonso M, Marin F, Pérez López R, Hernandez Boluda J, Echeveste Gutierrez MA, Odriozola J, Herrera P, Steegman JL, Conde E, Lopez P, Giraldo P, Boque C, Heredia B, Font AJ, Rodriguez RF, Rodriguez MJ, Batlle J, Stenke L, Lehmann S, Wadenvik H, Simonsson B, Markevärn B, Själander A, Richter J, Bjoreman M, Eriksson KM, Chalandon Y, Shih LY, Yao M, Wang MC, Jootar S, Bunworasate U, Ulkü B, Haznedar R, Undar B, Sahin B, Marin D, Smith G, Byrne J, Holyoake T, Kalaycio M, Akard L, Heaney M, Al Janadi A, Goldberg S, Powell B, Harker WG, Shea T, Gingrich R, Glass J, Paquette R, Siegrist C, Woodson M, Fehrenbacher L, Koh H, Flinn I, Arrowsmith E, Ervin T, Guerra M, Wallach H, Berry W, Burke J, Edenfield W, Guzley G, Davis J, Richards D, Schlossman D, Kolibaba K, Alemany C, Savin M, Robbins G, Lopez J, Goldman JM, Camm J, Schiffer CA, Sargent D.J., PANE, FABRIZIO, Saglio, G, Kim, Dw, Issaragrisil, S, le Coutre, P, Etienne, G, Lobo, C, Pasquini, R, Clark, Re, Hochhaus, A, Hughes, Tp, Gallagher, N, Hoenekopp, A, Dong, M, Haque, A, Larson, Ra, Kantarjian, Hm, Moiraghi, B, Perez, M, Greil, R, Valent, P, Bosly, A, Martiat, P, Noens, L, André, M, Verhoef, G, Conchon, M, Souza, C, Nonino, A, Hungria, V, Zanichelli, Ma, Colturato, V, Forrest, D, Lipton, Jh, Savoie, Ml, Delage, R, Lalancette, M, Quintero, G, Gomez, M, Klamova, H, Faber, E, Bjerrum, Ow, Fredriksen, H, Vestergaard, H, Marcher, C, Kamel, H, Elzawam, H, Porkka, K, Remes, K, Reiffers, J, Guilhot, F, Facon, T, Tulliez, M, Guerci Bresler, Ap, Nicolini, Fe, Charbonnier, A, Rea, D, Johnson Ansah, A, Legros, L, Harousseau, Jl, Rigal Huguet, F, Escoffre, M, Gardembas, M, Guyotat, D, Cahn, Jy, Gattermann, N, Ottmann, O, Niederwieser, D, Stegelmann, F, Schafhausen, P, Brümmendorf, T, Duyster, J, Blumenstengel, K, Scheid, C, Kneba, M, Kwong, Yl, Masszi, T, Petrini, M, Alimena, G, Di Raimondo, F, Rosti, G, Rotoli, B, Pane, Fabrizio, Pungolino, E, Amadori, S, Abruzzese, E, Fioritoni, G, Lauria, F, Bosi, A, Martelli, M, Rambaldi, A, Ferrara, F, Nobile, F, Gobbi, M, Carella, Am, Orlandi, Em, Leoni, P, Tiribelli, M, Levis, A, Imamura, M, Takahashi, N, Tsukamoto, N, Chiba, S, Nagai, T, Okamoto, S, Miura, O, Kurokawa, M, Ohnishi, K, Toba, K, Nakao, S, Tomita, A, Miyamura, K, Hino, M, Maeda, Y, Kimura, A, Kawaguchi, T, Miyazaki, Y, Nakaseko, C, Jinnai, I, Matsuda, A, Matsumura, I, Ishikawa, J, Ohyashiki, K, Okada, M, Usuki, K, Kobayashi, Y, Ohishi, K, Imai, K, Miyawaki, S, Kanda, Y, Park, Sy, Kim, Hj, Sohn, Sk, Lee, Kh, Jung, Cw, Ong, Tc, Gómez Almaguer, D, Kassack, J, Ossenkoppele, Gj, Gedde Dahl, T, Hjorth Hansen, H, Jedrzejczak, W, Dmoszynska, A, Starzak Dwozdz, J, Holowiecki, J, Kyrcz Krzemieñ, S, Kuliczkowski, K, Zaritsky, A, Turkina, A, Pospelova, T, Goh, Yt, Koh, Lp, Demitrovicova, L, Mistrik, M, Ruff, P, Louw, V, Dreosti, Lm, Novitzky, N, Cohen, G, Cervantes, F, Cañizo, C, de Paz, R, del Castillo, S, Perez Encinas, M, Sanz Alonso, M, Marin, F, Pérez López, R, Hernandez Boluda, J, Echeveste Gutierrez, Ma, Odriozola, J, Herrera, P, Steegman, Jl, Conde, E, Lopez, P, Giraldo, P, Boque, C, Heredia, B, Font, Aj, Rodriguez, Rf, Rodriguez, Mj, Batlle, J, Stenke, L, Lehmann, S, Wadenvik, H, Simonsson, B, Markevärn, B, Själander, A, Richter, J, Bjoreman, M, Eriksson, Km, Chalandon, Y, Shih, Ly, Yao, M, Wang, Mc, Jootar, S, Bunworasate, U, Ulkü, B, Haznedar, R, Undar, B, Sahin, B, Marin, D, Smith, G, Byrne, J, Holyoake, T, Kalaycio, M, Akard, L, Heaney, M, Al Janadi, A, Goldberg, S, Powell, B, Harker, Wg, Shea, T, Gingrich, R, Glass, J, Paquette, R, Siegrist, C, Woodson, M, Fehrenbacher, L, Koh, H, Flinn, I, Arrowsmith, E, Ervin, T, Guerra, M, Wallach, H, Berry, W, Burke, J, Edenfield, W, Guzley, G, Davis, J, Richards, D, Schlossman, D, Kolibaba, K, Alemany, C, Savin, M, Robbins, G, Lopez, J, Goldman, Jm, Camm, J, Schiffer, Ca, and Sargent, D. J.

Published
2010

32. Le sanctuaire de Mars Mullo (Alonnes, Sarthe) du Ve s. av. J.-C. au IVe s. ap. J.-C. État des recherches actuelles

Author

Guillaumet, Jean-Paul, Brouquier-Reddé, Véronique, Catherine, gruel, Allag , Claudine, Bazin, B., Bérard, François, Bertrand, B., Cormier, S, Delage, R., Depeyrot, Georges, Drost, V., Lejars, Thierry, Lefevre, Cathy, Loiseau, Christophe, Poupon, F., Archéologie, Terre, Histoire, Sociétés [Dijon] (ARTeHiS), Centre National de la Recherche Scientifique (CNRS)-Université de Bourgogne (UB)-Ministère de la Culture et de la Communication (MCC), Archéologie et Philologie d'Orient et d'Occident (AOROC), École normale supérieure - Paris (ENS Paris), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-École pratique des hautes études (EPHE), Université Paris sciences et lettres (PSL)-Centre National de la Recherche Scientifique (CNRS), and Centre National de la Recherche Scientifique (CNRS)

Subjects
[SHS.ARCHEO]Humanities and Social Sciences/Archaeology and Prehistory, ComputingMilieux_MISCELLANEOUS
Abstract

International audience

Published
2004

33. Mapping out social change in south India : a geographic information system and its applications

Author

Guilmoto, Christophe, Oliveau, S., Chasles, V., Delage, R., and Vella, S.

Subjects
PELERINAGE, SYSTEME D'INFORMATION GEOGRAPHIQUE, ANALYSE SPATIALE, FECONDITE, INFRASTRUCTURE, DISCRIMINATION SEXUELLE, BASE DE DONNEES, MOBILITE SPATIALE, ENFANT, RECENSEMENT, IRRIGATION, CHANGEMENT SOCIAL, MOBILITE SOCIALE, SANTE PUBLIQUE, URBANISATION, CARTOGRAPHIE, SEX RATIO, DONNEES STATISTIQUES
Published
2004

34. Development and description of GETT: a Genetic testing Evidence Tracking Tool

Author

Rousseau, F., Lindsay, C., Charland, M., Labelle, Y., Bergeron, J., Blancquaert, I., Delage, R., Gilfix, B., Miron, M., Mitchell, G., Oligny, L., Pazzagli, M., Mamotte, Cyril, Payne, D., Rousseau, F., Lindsay, C., Charland, M., Labelle, Y., Bergeron, J., Blancquaert, I., Delage, R., Gilfix, B., Miron, M., Mitchell, G., Oligny, L., Pazzagli, M., Mamotte, Cyril, and Payne, D.

Abstract

Background: The completion of the Human Genome Project has increased the pace of discovery of genetic markers for disease. Despite tremendous efforts in fundamental research, clinical applications still lag behind expectations, partly due to the lack of effective tools to systematically search for and summarize published data relative to the clinical assessment of new diagnostic molecular tests. Methods: Through a collaborative process using published tools and an expert panel, we developed a detailed checklist of the evidence that needs to be collected or produced to evaluate the potential usefulness of a new molecular diagnostic test. This tool is called GETT, for Genetic testing Evidence Tracking Tool. Results: GETT allows 1) researchers to summarize the current evidence and to identify knowledge gaps for further research and; 2) stakeholders to collect data related to a given molecular test and improve their decision-making process. GETT comprises 72 clearly defined items/questions, grouped into 10 categories and 26 sub-themes, including an overview of disease epidemiology and genetics, the available diagnostic tools, and their analytical and clinical performances, availability of quality control programs, laboratory and clinical best practice guidelines, clinical utility, and impact on health care and psycho-social, ethical and legal implications. It also includes a summary of the evidence available and attempts to prioritise knowledge gaps related to the testing. We also compare GETT to other existing frameworks. Conclusions: This systematic evidence-based tracking tool, which is more detailed than existing frameworks and provides clear definition for each item, will help streamline collection of the available evidence to appraise the potential for clinical application of new molecular diagnostic tests and prioritize research to produce the evidence-base relative to the clinical implementation of molecular diagnostic tests.

Published
2010

36. Long Term Follow-Up of a Randomized Trial Comparing Response Adapted (RA), Non-Cross Resistant Induction and Consolidation with Idarubicin/Cytarabine (IDAC) Followed by Mitoxantone/Etoposide (NOVE) Compared with Consolidation with High Dose Cytarabine (HDAC) in Adult Patients with AML. A Study by the Canadian Leukemia Studies Group (CLSG).

Author

Van der Jagt, Richard H., primary, Robinson, K., additional, Sheridan, D.P., additional, Delage, R., additional, Larratt, L.M., additional, Yetisir, L., additional, and Wells, G., additional

Published
2006
Full Text
View/download PDF

44. Planning and programming of the open cast mine at Venachat.

Author

Boutonnat H., Delage R., Boutonnat H., and Delage R.

Abstract

Data from prospecting boreholes, have made it possible to cut up the mineralised orebody in parallelepipes, each assigned to a certain tonnage of ore and uranium. A technical and economical optimisation program on a computer, fed with this data, led to the final layout of the pit, and to the distribution of the three important tonnages in each stepped face. Annual planning was then carried out in the framework of the annual production program of the division and a monthly check is made on the cumulative results per stepped face., Data from prospecting boreholes, have made it possible to cut up the mineralised orebody in parallelepipes, each assigned to a certain tonnage of ore and uranium. A technical and economical optimisation program on a computer, fed with this data, led to the final layout of the pit, and to the distribution of the three important tonnages in each stepped face. Annual planning was then carried out in the framework of the annual production program of the division and a monthly check is made on the cumulative results per stepped face.

46. A Multicenter Randomized Trial Comparing Response-Adapted (RA), Non-Cross-Resistant Induction and Consolidation with Idarubicin/Cytarabine (IDAC) Followed by Mitoxantrone/Etoposide (NOVE) Compared with Consolidation with High Dose Cytarabine (HDAC) in Adult Patients with AML. A Study by the Canadian Leukemia Studies Group (CLSG).

Author

van der Jagt, Richard H.C., Robinson, K.S., Sheridan, D.P., Delage, R., Larratt, L.M., Yetisir, E., and Wells, G.A.

Abstract

Background: A CLSG pilot rx'd 140 pts.with Response Adapted Rx(RA) with Idarubicin 12 mg/m2d1-3 & Ara-C 200 mg/m2 d1-7(IDAC);followed by IDAC II, then Mitoxantrone10 mg/m2&VP-16 100 mg/m2d1-5(NOVE), if in CR after IDAC, & NOVE x2 if they had persistent blasts @ d14 or @ recovery. CR rate was 74% in pts age15–80.DFS and OS were favourable @ 20 mos & 47 mos in pts ≤ 60. A CALGB study demonstrated the advantage of consolidation with high dose Ara-C(HDAC).We chose to compare HDAC with RA.

Published
2005
Full Text
View/download PDF

48. Voyageurs immobiles : la géographie idéelle des Kulung Rai du Népal

Author

Grégoire Schlemmer, Centre d'Études de l'Inde et de l'Asie du Sud (CEIAS), École des hautes études en sciences sociales (EHESS)-Centre National de la Recherche Scientifique (CNRS), Unite de recherche migrations et sociétés (URMIS), Centre National de la Recherche Scientifique (CNRS)-Université Nice Sophia Antipolis (... - 2019) (UNS), COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-Université Paris Diderot - Paris 7 (UPD7)-Institut de recherche pour le développement [IRD] : UR205, Claveyrolas, M. (ed.), Delage, R. (ed.), Université Nice Sophia Antipolis (1965 - 2019) (UNS), COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-Université Paris Diderot - Paris 7 (UPD7)-Institut de recherche pour le développement [IRD] : UR205-Centre National de la Recherche Scientifique (CNRS), Université Nice Sophia Antipolis (... - 2019) (UNS), and Université Côte d'Azur (UCA)-Université Côte d'Azur (UCA)-Université Paris Diderot - Paris 7 (UPD7)-Institut de recherche pour le développement [IRD] : UR205-Centre National de la Recherche Scientifique (CNRS)

Subjects
NEPAL, rituel, pèlerinage, [SHS.ANTHRO-SE]Humanities and Social Sciences/Social Anthropology and ethnology, anthropologie, géographie
Abstract

International audience; Les Kulung Rai forment une société fortement territorialisée. Environ la moitié des 30 ooo Kulung occupent leur vallée de référence-la vallée de l'Hongu, au pied de l'Everest-, où ils se répartissent en une dizaine de villages vivant d'agriculture en terrasse et d'un peu d'élevage, et ce depuis une ving-taine de générations, soit environ quatre à cinq siècles, si l'on se fonde sur leurs généalogies. À l'image des autres groupes Rai et Kirant Oes ensembles ethniques auxquels ils se rattachent), les Kulung se distinguent des autres populations dites« tribales» du centre et de l'ouest du Népal par une histoire singulière. Après leur intégration par conquête dans le royaume du Népal, à la fln du xvme siècle, ils se sont vus reconnaitre une certaine autonomie poli ti~ foncière sur leur ancien territoire de chasse et d'essartage, waltkha-dibuka, devenu dans le langage administratif népalais kipat 1 • Bien que progressive-ment réduite, jusqu'à sa suppression vers les années 1950, cette autonomie contribue à expliquer-ou à renforcer-le lien existant entre les Kulung et leur territoire ancestral, capkuQ: «le lieu des mânes». La manière dont ils se désignent vis-à-vis des étrangers témoigne d'ailleurs de cet ancrage territorial: jusqu'aux années 1960, seuls les chefs fonciers, talulcdar, étaient nommés Rai, tous les autres habitants s'appelant]imi, une déformation dejamin,le «sol» etjamindoe; «propriétaire foncier» (Schlemmer 201oa). Le terme même « kulung »a. en plus de son acception généalogique Oes descendants des deux frères fondateurs chemsi et Tamsi), un sens géographique, désignant alors l'ensemble des Rai de la vallée (soit les Kulung proprement dits et le groupe voisin des Nachering). Les Kulung aiment aussi à se nommer cartcha, «les enfants du territoire», un terme qui exprime un sentiment d'autochtonie. La vallée de l'Hongu reste aussi le territoire de référence pour les migrants kulung, qui l'ont quitté parfois depuis plusieurs générations. Cet ancrage territorial structure enfin le domaine religieux qui nous intéresse ici. Dans Purufdrt}ta 34, pp. :m-247-227

Published
2017

49. Reduced Intensity transplantation vs chemotherapy in CR1. A prospective, pseudorandomized study in 50-70 year old AML patients.

Author

Brune M, Kiss T, Anderson H, Nicklasson M, Delage R, Finke J, Gedde-Dahl T, Hébert J, Höglund M, Kaare A, Lazarevic V, Möllgård L, Remes K, Ritchie D, Spyridonidis A, Sabloff M, Spearing R, Wallhult E, and Ljungman P

Abstract

The aim of this prospective, international multicenter, pseudorandomized study comparing RICT HCT to standard-of-care chemotherapy in intermediate- or high-risk AML patients 50-70 years using the donor versus no-donor concept. Part 1 included only patients with potential family donors (RD) at the date of HLA-typing of the first potential sibling or CR-date, if later. Part 2 allowed the inclusion of patients without a possible sibling donor using the start of an unrelated donor (URD) search as inclusion date. 360 patients were registered and 309 analyzed. The median follow-up was 47 months (1-168). There was no difference in overall survival (OS) between the RD (n = 124) and the Control (n = 77) groups (p = 0.50, 3-year OS RD: 0.41(95% CI; 0.32-0.50); Controls: 0.49 (95% CI; 0.37-0.59)). The main cause of death was relapse (67% RD; 88% Controls). In Part 2, the 3-year OS was 0.60 (95% CI 0.50-0.70) for URD-HCT (n = 86) and 0.37 (95% CI 0.13-0.62) for Controls (n = 20), respectively (p = 0.10). When analyzing transplanted patients (Part 2), the OS at 3-years was higher for URD-HCT than RD-HCT (0.67 (0.55-0.76) vs. 0.42 (0.26-0.57; p = 0.005). This study doesn't support elderly HLA-identical siblings as donors for older AML patients undergoing a RICT allogeneic HCT in first CR., (© 2024. The Author(s).)

Published
2024
Full Text
View/download PDF

50. An algorithm for simplified recurrence analysis.

Author

Delage R and Nakata T

Abstract

Recurrence analysis applications are hindered by several issues including the selection of critical parameters, noise sensitivity, computational complexity, or the analysis of non-stationary systems. Great progresses have been made by the community to address these issues individually, yet the diversity of resulting techniques with often additional parameters as well as a lack of consensus still impedes its use by nonspecialists. We present a procedure for simplified recurrence analysis based on compact recurrence plots with automatized parameter selection and enhanced noise robustness, and that are suited to the analysis of complex non-stationary systems. This approach aims at supporting the expansion of recurrence analysis for currently challenging or future applications such as for large systems, on-site studies, or using machine learning. The method is demonstrated on both synthetic and real data showing promising results., (© 2024 Author(s). Published under an exclusive license by AIP Publishing.)

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results